<DOC>
	<DOCNO>NCT01271010</DOCNO>
	<brief_summary>This multi-center , single-arm study evaluate efficacy safety rituximab combination fludarabine cyclophosphamide participant B-cell chronic lymphocytic leukemia ( CLL ) favorable somatic status .</brief_summary>
	<brief_title>A Study Rituximab Combination With Fludarabine Cyclophosphamide Participants With Chronic Lymphocytic Leukemia Favorable Somatic Status</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>Diagnosis previously untreated Bcell CLL confirm immunophenotypically For participant , age 6070 year : Cumulative Illness Rating Scale ( CIRS ) comorbidity score less equal ( &lt; /= ) 6 Binet stage B , C A progression Life expectancy great equal ( &gt; /= ) 12 month Eastern Cooperative Oncology Group ( ECOG ) performance status ( PS ) 02 Women child bear potential men agree use highly reliable contraceptive method throughout treatment period within 12 month treatment completion Participants smallcell lymphoma Participants autoimmune hemolytic anemia Concomitant malignant disease enrollment , except basal cell carcinoma skin Chemotherapy concomitant malignant disease give within 12 month prior study enrollment Participants Richter 's Syndrome Participants symptomatic Hepatitis B infection Any clinically significant infection could cure prior enrollment , include Human Immunodeficiency Virus ( HIV ) infection Creatinine clearance le ( &lt; ) 30 milliliter per minute ( mL/min ) Participants congestive heart failure ( CHF ) New York Heart Association ( NYHA ) IIIIV Participants liver failure acute hepatitis etiology Any medical mental condition may preclude receive entire course protocol specify treatment signing informed consent History anaphylactic reaction murine antibody , protein , ingredient rituximab Pregnancy breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>